How are hiring trends shaping up for the future of health care?
On January 6, 2023, the FDA granted lecanemab-irmb (Leqembi) accelerated approval for treating mild cognitive impairment and mild dementia in patients with Alzheimer disease.
Ser/dex is a dexmethylphenidate-based prodrug for ADHD in patients 6 years and older.
Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, explore real-world examples of AI giving time back to pharmacists.
Disadvantaged groups are feeling the sting of health care costs—so much so that many are foregoing health care because they can’t pay for it.
What pharmacists need to consider before selling CBD in their stores.
Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves
Apetamin has been promoted worldwide as a weight gain supplement—but what are the dangers of misuse?
Tips to help your pharmacy stand out as a knowledgeable CBD retailer.
A discussion on the new nonopioid selective NaV1.8 pain signal inhibitor with Madison Irwin, PharmD, BCPS.
At the state level, medication treatment rates ranged from 17.7% in Kansas to 82.8% in Maine.
The researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.
Tryvio was given FDA approval on March 19, 2024.
Cancer care is expensive, but pharmacists can help.
The majority of persistent irAEs were hypothyroid, adrenal insufficiency, arthritis, dermatitis or pruritis, and hypophysitis.
In this article, we will review the evidence describing a possible link between vitamin D and COVID-19.
How pharmacies will pay for the Medicare Drug Price Negotiation Program
Five medications are currently approved by the FDA for chronic weight management.
Clinical consultant pharmacists offer an individualized approach to the needs of long-term care facilities.
Melphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
Ollin Sykes, CPA, CITP, and Scotty Sykes, CPA, CFP, discuss the business landscape after COVID within pharmacies and 5 objectives for focusing on growth again.
Several institutions have published guidance on how to treat patients hospitalized with COVID-19.
GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
As respiratory viruses and COVID-19 variants lurk seemingly everywhere, here’s how best to detect and differentiate.
An essay by Lord Simon Woolley that was published in BMJ calls on the medical community to speak up on how failed drug laws disproportionately harm black communities.